A share price of Integra Lifesciences Holdings Corp [IART] is currently trading at $13.58, down -2.02%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IART shares have gain 13.07% over the last week, with a monthly amount glided 3.03%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Integra Lifesciences Holdings Corp [NASDAQ: IART] stock has seen the most recent analyst activity on March 31, 2025, when Argus upgraded its rating to a Buy. Previously, Morgan Stanley started tracking the stock with Underweight rating on December 02, 2024, and set its price target to $20. On October 07, 2024, upgrade upgraded it’s rating to Neutral. Citigroup downgraded its rating to a Sell and decreased its price target to $23 on July 30, 2024. BTIG Research downgraded its rating to a Sell but $22 remained the price target by the analyst firm on July 30, 2024. Wells Fargo downgraded its rating to Equal Weight for this stock on May 07, 2024, and downed its price target to $25. In a note dated May 07, 2024, Oppenheimer downgraded an Perform rating on this stock.
Integra Lifesciences Holdings Corp experienced fluctuations in its stock price throughout the past year between $10.87 and $27.13. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Integra Lifesciences Holdings Corp [NASDAQ: IART] shares were valued at $13.58 at the most recent close of the market. An investor can expect a potential return of 10.46% based on the average IART price forecast.
Analyzing the IART fundamentals
Trailing Twelve Months sales for Integra Lifesciences Holdings Corp [NASDAQ:IART] were 1.64B which represents 5.57% growth. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.28%, Pretax Profit Margin comes in at -0.33%, and Net Profit Margin reading is -0.3%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.39 and Total Capital is -0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.93.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Integra Lifesciences Holdings Corp [NASDAQ:IART] is 3.14. Further, the Quick Ratio stands at 1.80, while the Cash Ratio is 0.64. Considering the valuation of this stock, the price to sales ratio is 0.66, the price to book ratio is 1.02.
Transactions by insiders
Recent insider trading involved GRAVES JEFFREY A, Director, that happened on Nov 05 ’25 when 9000.0 shares were purchased.
